REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/24/2025
Back to search
Official data from USPTO
OCUVANT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OCUVANT
ST13
US500000088252326Class
5, 42, 44
Filing
88252326
Registration
6203088
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
11/25/2025
Trademark type
Word
Nice classes
5, 42, 44
Filing date
01/07/2019
Registration date
11/24/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/24/2020
Last transaction
11/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Basel, CH
Examiner
ANDERSON, CASSONDRA CR
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Roivant Sciences GmbH
Representatives
ALLISON STRICKLAND RICKETTS FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for human use for the treatment of ophthalmic diseasesdisorders and conditionsother than vitamins and mineral supplements; biologic preparations for medical and therapeutic purposes for the treatment of ophthalmic diseasesdisorders and conditions
Class 42
Scientific and technological servicesmedical researchscientific research and analysis in the field of pharmaceuticals and biomedicine; pharmaceuticalbiomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparationsclinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticalsbiomedicineclinical trials and post-market trials
Class 44
Providing health and medical information; providing information relating to the diagnosticprophylactic and therapeutic properties of pharmaceutical preparationsother than vitamins and mineral supplementsbiologic preparations for the prevention and treatment of diseasesdisorders and conditions
Publications
History of USPTO decisions and trademark events.
30 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/24/2020
TMBN
TTAB RELEASE CASE TO TRADEMARKS
10/15/2020
OP.T
OPPOSITION TERMINATED NO. 999999
10/15/2020
OP.D
OPPOSITION DISMISSED NO. 999999
10/15/2020
OP.I
OPPOSITION INSTITUTED NO. 999999
02/12/2020
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
11/11/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/15/2019
PUBO
PUBLISHED FOR OPPOSITION
10/15/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/25/2019
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
09/10/2019
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
08/30/2019
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
08/27/2019
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
08/23/2019
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
08/16/2019
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
08/09/2019
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
08/07/2019
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
08/02/2019
ALIE
ASSIGNED TO LIE
07/30/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/22/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/20/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/19/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/19/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/19/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/07/2019
GNRT
NON-FINAL ACTION E-MAILED
02/07/2019
CNRT
NON-FINAL ACTION WRITTEN
02/07/2019
DOCK
ASSIGNED TO EXAMINER
02/06/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/28/2019
NWAP
NEW APPLICATION ENTERED
01/10/2019
Continuous trademark protection
Get notified about every new filing that threatens OCUVANT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.